# Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/adjuvant-chemotherapy-of-s-1-versus-gemcitabine-for-resected-pancreatic-cancer-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Katsuhiko Uesaka,Narikazu Boku,Akira Fukutomi,Yukiyasu Okamura,Masaru Konishi,Ippei Matsumoto,Yuji Kaneoka,Yasuhiro Shimizu,Shoji Nakamori,Hirohiko Sakamoto,Soichiro Morinaga,Osamu Kainuma,Koji Imai,Naohiro Sata,Shoichi Hishinuma,Hitoshi Ojima,Ryuzo Yamaguchi,Satoshi Hirano,Takeshi Sudo,Yasuo Ohashi |
| Citations | 1,133 |
| DOI | 10.1016/s0140-6736(16)30583-9 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2412717755 |
| PMID | 27265347 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Yasuo Ohashi](https://scholariq.org/researchers/yasuo-ohashi/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)

## Paper topics

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Colorectal and Anal Carcinomas](https://scholariq.org/topics/colorectal-and-anal-carcinomas/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.